Outcome of 622 Adults With Asymptomatic, Hemodynamically Significant Aortic Stenosis During Prolonged Follow-Up
By Patricia A. Pellikka, M. Sarano, Rick A. Nishimura, J. Malouf, Kent R. Bailey, C. Scott, M. Barnes, A. Tajik. Circulation, 2005
858 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/fa985283a8638d347be846d64c42a5dc55b41b78
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Epidemiology
Citations in the corpus
- Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (2006, background): “• Echocardiography: valve calcification, peak aortic jet velocity [88– 91], LVEF [90], rate of haemodynamic progression [89], increase in gradient with exercise [80, 81], excessive LV hypertrophy [92],”
- Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. (2009, neutral): “1,2,12,13 Cardiac catheterization is not recommended except in cases where echocardiography is non-diagnostic or is discrepant with clinical data.”
- Calcific aortic stenosis: a disease of the valve and the myocardium. (2012, background): “The rate at which patients with AS move toward symptoms, adverse events, and the need for surgery is determined both by the severity of the valve narrowing and by the myocardial hypertrophic response (2,3).”
- Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). (2012, neutral): “It should also be considered in the patients presenting a fall in blood pressure below baseline.(21,83,90,93) Surgery should be considered in patients at low operative risk,”
- 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “Prophylaxis against infective endocarditis (IE) is reasonable for the following patients at highest risk for adverse outcomes from IE before dental procedures that involve manipulation of gingival tissue, manipulation of the periapical region of teeth, or perforation of the oral mucosa (41-43), (Lev”